A detailed history of Highland Capital Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Highland Capital Management, LLC holds 7,731 shares of VRTX stock, worth $3.78 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
7,731
Previous 7,696 0.45%
Holding current value
$3.78 Million
Previous $3.13 Million 3.19%
% of portfolio
0.19%
Previous 0.19%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$407.69 - $446.08 $14,269 - $15,612
35 Added 0.45%
7,731 $3.23 Million
Q4 2023

Jan 17, 2024

SELL
$343.0 - $410.68 $8,575 - $10,267
-25 Reduced 0.32%
7,696 $3.13 Million
Q3 2023

Nov 14, 2023

SELL
$338.18 - $362.46 $37,876 - $40,595
-112 Reduced 1.43%
7,721 $2.68 Million
Q2 2023

Aug 09, 2023

SELL
$314.42 - $351.91 $18,236 - $20,410
-58 Reduced 0.74%
7,833 $2.76 Million
Q1 2023

May 11, 2023

BUY
$283.23 - $323.1 $2.23 Million - $2.55 Million
7,891 New
7,891 $2.49 Million
Q4 2022

Feb 07, 2023

SELL
$285.76 - $321.48 $19,431 - $21,860
-68 Reduced 0.83%
8,076 $2.33 Million
Q3 2022

Nov 09, 2022

BUY
$273.83 - $305.53 $2,738 - $3,055
10 Added 0.12%
8,144 $2.36 Million
Q1 2022

Apr 19, 2022

BUY
$221.42 - $260.97 $11,956 - $14,092
54 Added 0.67%
8,134 $2.12 Million
Q4 2021

Jan 28, 2022

SELL
$177.01 - $223.45 $354 - $446
-2 Reduced 0.02%
8,080 $1.77 Million
Q3 2021

Oct 25, 2021

SELL
$181.39 - $202.99 $155,632 - $174,165
-858 Reduced 9.6%
8,082 $1.47 Million
Q2 2021

Jul 30, 2021

SELL
$187.49 - $221.1 $51,747 - $61,023
-276 Reduced 2.99%
8,940 $1.8 Million
Q1 2021

Apr 27, 2021

SELL
$207.02 - $241.31 $160,854 - $187,497
-777 Reduced 7.78%
9,216 $1.98 Million
Q4 2020

Jan 21, 2021

SELL
$207.01 - $276.09 $91,705 - $122,307
-443 Reduced 4.24%
9,993 $2.36 Million
Q3 2020

Oct 16, 2020

BUY
$255.65 - $303.1 $34,768 - $41,221
136 Added 1.32%
10,436 $2.84 Million
Q2 2020

Jul 22, 2020

BUY
$225.48 - $295.8 $206,990 - $271,544
918 Added 9.78%
10,300 $2.99 Million
Q1 2020

May 05, 2020

BUY
$199.77 - $247.81 $1.87 Million - $2.32 Million
9,382 New
9,382 $2.23 Million
Q3 2018

Oct 17, 2018

SELL
$167.73 - $192.74 $536,400 - $616,382
-3,198 Closed
0 $0
Q2 2018

Jul 18, 2018

SELL
$145.72 - $169.96 $6,411 - $7,478
-44 Reduced 1.36%
3,198 $544,000
Q1 2018

Apr 16, 2018

BUY
$151.6 - $177.13 $69,736 - $81,479
460 Added 16.53%
3,242 $528,000
Q4 2017

Jan 26, 2018

BUY
$137.28 - $155.55 $15,924 - $18,043
116 Added 4.35%
2,782 $417,000
Q3 2017

Oct 10, 2017

BUY
$148.13 - $162.24 $394,914 - $432,531
2,666
2,666 $405,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $125B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Highland Capital Management, LLC Portfolio

Follow Highland Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management, LLC with notifications on news.